Author Correction: C16orf72/HAPSTR1/TAPR1 functions with BRCA1/Senataxin to modulate replication-associated R-loops and confer resistance to PARP disruption

• Abhishek Bharadwaj Sharma,
• Muhammad Khairul Ramlee,
• Joel Kosmin,
• Martin R. Higgs,
• Amy Wolstenholme,
• George E. Ronson,
• Dylan Jones,
• Daniel Ebner,
• Noor Shamkhi,
• David Sims,
• Paul W. G. Wijnhoven,
• Josep V. Forment,
• Ian Gibbs-Seymour,
• Nicholas D. Lakin

Affiliations

Abhishek Bharadwaj Sharma

Department of Biochemistry, University of Oxford

Muhammad Khairul Ramlee

Department of Biochemistry, University of Oxford

Joel Kosmin

Department of Biochemistry, University of Oxford

Martin R. Higgs

Institute of Cancer and Genomic Sciences, University of Birmingham

Amy Wolstenholme

Department of Biochemistry, University of Oxford

George E. Ronson

Department of Biochemistry, University of Oxford

Dylan Jones

Target Discovery Institute, Nuffield Department of Medicine, University of Oxford

Daniel Ebner

Target Discovery Institute, Nuffield Department of Medicine, University of Oxford

Noor Shamkhi

Department of Biochemistry, University of Oxford

David Sims

Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital

Paul W. G. Wijnhoven

Early Oncology R&D, AstraZeneca, 1 Francis Crick Avenue, Cambridge Biomedical Campus

Josep V. Forment

Early Oncology R&D, AstraZeneca, 1 Francis Crick Avenue, Cambridge Biomedical Campus

Ian Gibbs-Seymour

Department of Biochemistry, University of Oxford

Nicholas D. Lakin

Department of Biochemistry, University of Oxford